Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asako Nogami

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical and Translational Hepatology|August 14, 2023
Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAMTakashi Kobayashi, Michihiro Iwaki, Asako Nogami, et al.
International Journal of Molecular Sciences|October 14, 2022
Current Research on the Pathogenesis of NAFLD/NASH and the Gut-Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut SyndromeTakashi Kobayashi, Michihiro Iwaki, Atsushi Nakajima, et al.
Journal of Medical Ultrasonics (2001)|August 5, 2020
Advances in ultrasound elastography for nonalcoholic fatty liver diseaseMasato Yoneda, Yasushi Honda, Asako Nogami, et al.
Gut and Liver|August 10, 2023
Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary CareMasato Yoneda, Takashi Kobayashi, Michihiro Iwaki, et al.
Clinical Journal of Gastroenterology|January 5, 2021
Lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection treated by radiofrequency ablationAsako Nogami, Satoru Saito, Hiromasa Hasegawa, et al.
Nutrients|February 25, 2023
Impact of Sarcopenia on Non-Alcoholic Fatty Liver DiseaseMichihiro Iwaki, Takashi Kobayashi, Asako Nogami, et al.
Drugs|June 18, 2021
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic AgentsSho Hasegawa, Masato Yoneda, Yusuke Kurita, et al.
Life (Basel, Switzerland)|November 25, 2023
Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A ReviewKoki Nagai, Kazuki Nagai, Michihiro Iwaki, et al.
Expert Opinion on Emerging Drugs|March 12, 2024
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitisMichihiro Iwaki, Masato Yoneda, Naohiro Wada, et al.
Interventional Radiology (Higashimatsuyama-Shi (Japan)|October 10, 2025
Modified Sharp Recanalization for Inferior Vena Cava Occlusion in Patient with Budd-Chiari SyndromeShingo Koyama, Yuya Koike, Asako Nogami, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical and Translational Hepatology|August 14, 2023
Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAMTakashi Kobayashi, Michihiro Iwaki, Asako Nogami, et al.
International Journal of Molecular Sciences|October 14, 2022
Current Research on the Pathogenesis of NAFLD/NASH and the Gut-Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut SyndromeTakashi Kobayashi, Michihiro Iwaki, Atsushi Nakajima, et al.
Journal of Medical Ultrasonics (2001)|August 5, 2020
Advances in ultrasound elastography for nonalcoholic fatty liver diseaseMasato Yoneda, Yasushi Honda, Asako Nogami, et al.
Gut and Liver|August 10, 2023
Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary CareMasato Yoneda, Takashi Kobayashi, Michihiro Iwaki, et al.
Clinical Journal of Gastroenterology|January 5, 2021
Lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection treated by radiofrequency ablationAsako Nogami, Satoru Saito, Hiromasa Hasegawa, et al.
Nutrients|February 25, 2023
Impact of Sarcopenia on Non-Alcoholic Fatty Liver DiseaseMichihiro Iwaki, Takashi Kobayashi, Asako Nogami, et al.
Drugs|June 18, 2021
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic AgentsSho Hasegawa, Masato Yoneda, Yusuke Kurita, et al.
Life (Basel, Switzerland)|November 25, 2023
Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A ReviewKoki Nagai, Kazuki Nagai, Michihiro Iwaki, et al.
Expert Opinion on Emerging Drugs|March 12, 2024
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitisMichihiro Iwaki, Masato Yoneda, Naohiro Wada, et al.
Interventional Radiology (Higashimatsuyama-Shi (Japan)|October 10, 2025
Modified Sharp Recanalization for Inferior Vena Cava Occlusion in Patient with Budd-Chiari SyndromeShingo Koyama, Yuya Koike, Asako Nogami, et al.
Pageof 5